Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Amir, Toor"'
Autor:
Gary L. Simmons, Roy Sabo, Rehan Qayyum, May Aziz, Erika Martin, Robyn J. Bernard, Manjari Sriparna, Cody McIntire, Elizabeth Krieger, Donald F. Brophy, Ramesh Natarajan, Alpha Fowler III, Catherine H. Roberts, Amir Toor
Publikováno v:
eJHaem, Vol 5, Iss 5, Pp 1043-1047 (2024)
Abstract Introduction Intravenous vitamin C was administered following hematopoietic stem cell transplant to mitigate nonrelapse mortality (NRM) in a Phase II clinical trial. Methods Patients with advanced hematologic malignancies received IV vitamin
Externí odkaz:
https://doaj.org/article/f81e7a694b934a8f8735484b92454cb6
Autor:
Viktoriya Zelikson, Roy Sabo, Myrna Serrano, Younus Aqeel, Savannah Ward, Taha Al Juhaishi, May Aziz, Elizabeth Krieger, Gary Simmons, Catherine Roberts, Jason Reed, Gregory Buck, Amir Toor
Publikováno v:
Clinical & Translational Immunology, Vol 12, Iss 7, Pp n/a-n/a (2023)
Abstract Objectives Immune recovery following haematopoietic cell transplantation (HCT) functions as a dynamical system. Reducing the duration of intense immune suppression and augmenting antigen presentation has the potential to optimise T‐cell re
Externí odkaz:
https://doaj.org/article/ec09429bfc8f41c29d55e0073d8b2eca
Autor:
Alessandra Vecchié, Georgia Thomas, Edoardo Bressi, Aldo Bonaventura, Justin M. Canada, David Chuquin, Dinesh Kadariya, Usman Piracha, Delia Endicott, Roshanak Markley, Amir Toor, Michael Hess, Antonio Abbate
Publikováno v:
Cardio-Oncology, Vol 7, Iss 1, Pp 1-11 (2021)
Abstract Background Hematopoietic cell transplantation (HCT) is an established and potentially curative therapeutic option for hematologic cancers. HCT survivors are at risk of developing long-term complications impacting on morbidity and mortality.
Externí odkaz:
https://doaj.org/article/078f38647efb4b74ae18aaeebe8d3fa2
Publikováno v:
Clinical Case Reports, Vol 9, Iss 10, Pp n/a-n/a (2021)
Abstract Hemorrhage in patients with hematologic malignancies is often difficult to manage as many of these patients also have coagulopathy and thrombocytopenia of varying severity. Recombinant factor VIIa is a FDA‐approved agent for management of
Externí odkaz:
https://doaj.org/article/8c32758b797d4d20b4dd364c0121569e
Publikováno v:
Biological Research For Nursing. 25:220-226
Despite increased sophistication in DNA methylation (DNAm) measurement and methods, conducting studies in specific populations such as the hematopoietic stem cell transplant (HCT) population, presents unique challenges and study design considerations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42b027b80e58dd1ba2fc6d44018e476c
https://doi.org/10.1177/10998004221132251
https://doi.org/10.1177/10998004221132251
Autor:
Andrey Mikheikin, Anita Olsen, Kevin Leslie, Freddie Russell-Pavier, Andrew Yacoot, Loren Picco, Oliver Payton, Amir Toor, Alden Chesney, James K. Gimzewski, Bud Mishra, Jason Reed
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-9 (2017)
Physical mapping of DNA can be used to detect structural variants and for whole-genome haplotype assembly. Here, the authors use CRISPR-Cas9 and high-speed atomic force microscopy to ‘nanomap’ single molecules of DNA.
Externí odkaz:
https://doaj.org/article/a68808d05e344a9c825d7924d933f9bc
Publikováno v:
Biological research for nursing.
Background Blood cancers may be potentially cured with hematopoietic stem cell transplantation (HCT); however, standard pre-assessments for transplant eligibility do not capture all contributing factors for transplant outcomes. Epigenetic biomarkers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1d40ae530fc87218b56209479f1a134
https://pubmed.ncbi.nlm.nih.gov/36321693
https://pubmed.ncbi.nlm.nih.gov/36321693
Autor:
Vishal Koparde, Badar Abdul Razzaq, Tara Suntum, Roy Sabo, Allison Scalora, Myrna Serrano, Max Jameson-Lee, Charles Hall, David Kobulnicky, Nihar Sheth, Juliana Feltz, Daniel Contaifer, Dayanjan Wijesinghe, Jason Reed, Catherine Roberts, Rehan Qayyum, Gregory Buck, Michael Neale, Amir Toor
Publikováno v:
PLoS ONE, Vol 12, Iss 12, p e0187771 (2017)
Quantitative relationship between the magnitude of variation in minor histocompatibility antigens (mHA) and graft versus host disease (GVHD) pathophysiology in stem cell transplant (SCT) donor-recipient pairs (DRP) is not established. In order to elu
Externí odkaz:
https://doaj.org/article/14e9c1ee44cc43949edbbc3f308828d3
Autor:
Viktoriya Zelikson, Roy Sabo, Myrna Serrano, Younus Aqeel, Savannah Ward, Taha Al Juhaishi, May Aziz, Elizabeth Krieger, Gary Simmons, Catherine Roberts, Jason Reed, Gregory Buck, Amir Toor
Reduced intensity conditioning (RIC) is fraught with risk for disease relapse. This may be overcome by donor T cell alloreactivity. Reducing the duration of intense immune suppression in the early term following transplantation may create an immunolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ce606adbf8c8c8c6fff7ea95fe5abf3
https://doi.org/10.1101/2022.04.22.22274154
https://doi.org/10.1101/2022.04.22.22274154
Autor:
Viktoriya Zelikson, Gary Simmons, Natasha Raman, Elizabeth Krieger, Anatevka Rebiero, Kelly Hawks, May Aziz, Catherine Roberts, Jason Reed, Ronald Gress, Amir Toor
Alloreactivity forms the basis of allogeneic hematopoietic cell transplantation (HCT), with donor derived T cell response to recipient antigens mediating clinical responses either in part or entirely. These encompass the different manifestations of g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d6c79979e7afccb583763a47ce997c4
https://doi.org/10.1101/2021.05.21.21257336
https://doi.org/10.1101/2021.05.21.21257336